Not applicableStudy completedNCT00004138What this trial is testingPositron Emission Tomography for Detecting Non-small Cell Lung CancerWho this might be right forLung Cancer Alliance for Clinical Trials in Oncology 303
Not applicableNo Longer AvailableNCT03874455What this trial is testingTazemetostat Expanded Access Program for Adults With Solid TumorsWho this might be right forEpithelioid Sarcoma (Ex-US Only)Spindle Cell SarcomaSinonasal Carcinoma+17 more Epizyme, Inc.
Not applicableUnknownNCT02946216What this trial is testingALK/ROS1/MET Mutations on Plasma ctDNA in Patients With NSCLCWho this might be right forNon-small Cell Lung Cancer Stage IIINon-Small-Cell Lung Cancer MetastaticAdenocarcinoma of Lung+1 more First People's Hospital of Hangzhou 200
Early research (Phase 1)Study completedNCT05867121What this trial is testingEvaluate Safety, Pharmacokinetics, & Activity of RO7496353 in Combination With a Checkpoint Inhibitor With or Without Standard-of-care Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors; Urothelial Carcinoma Substudy in Association With RO7496353 Study GO44010Who this might be right forNon-small Cell Lung CancerGastric CancerPancreatic Ductal Adenocarcinoma Genentech, Inc. 102
Testing effectiveness (Phase 2)UnknownNCT00178698What this trial is testingHyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic TumorsWho this might be right forNeuroendocrine CancerSmall Cell Lung CancerNon-Small Cell Lung Cancer+1 more The University of Texas Health Science Center, Houston 36
Early research (Phase 1)Looking for participantsNCT05983432What this trial is testingEvaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid TumorsWho this might be right forNon Small Cell Lung CancerEsophageal CancerSmall Cell Lung Cancer+7 more SystImmune Inc. 540
Large-scale testing (Phase 3)Study completedNCT01719536What this trial is testingIcotinib Versus First-line Chemotherapy Plus Maintenance Treatment in EGFR Positive Lung Adenocarcinoma PatientsWho this might be right forNSCLC Betta Pharmaceuticals Co., Ltd. 296
Testing effectiveness (Phase 2)Active Not RecruitingNCT03110978What this trial is testingStereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung CancerWho this might be right forLung Atypical Carcinoid TumorLung Neuroendocrine NeoplasmLung Non-Small Cell Squamous Carcinoma+11 more M.D. Anderson Cancer Center 140
Testing effectiveness (Phase 2)Study completedNCT02664935What this trial is testingNational Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung CancerWho this might be right forNon-Small Cell Lung CancerCarcinoma, Squamous CellAdenocarcinoma University of Birmingham 423
Early research (Phase 1)Study completedNCT03502330What this trial is testingAPX005M With Nivolumab and Cabiralizumab in Advanced Melanoma, Non-small Cell Lung Cancer or Renal Cell CarcinomaWho this might be right forAdvanced MelanomaNon-small Cell Lung CancerRenal Cell Carcinoma Yale University 42
Testing effectiveness (Phase 2)Study completedNCT00950365What this trial is testingPemetrexed Disodium With or Without Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV or Recurrent Non-Small Cell Lung CancerWho this might be right forBronchioloalveolar CarcinomaLarge Cell Lung CarcinomaLung Adenocarcinoma+3 more Albert Einstein College of Medicine 79
Early research (Phase 1)Study completedNCT00753415What this trial is testingV934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)Who this might be right forNon-Small Cell Lung CarcinomaBreast CancerMelanoma+5 more Merck Sharp & Dohme LLC 37
Not applicableStudy completedNCT04385147What this trial is testingAdvanced Endoscopy During COVID-19Who this might be right forCholangitis, Secondary BiliaryCholangiocarcinomaObstructive Jaundice+3 more Al-Azhar University 670
Early research (Phase 1)Ended earlyNCT02628535What this trial is testingSafety Study of MGD009 in B7-H3-expressing TumorsWho this might be right forMesotheliomaBladder CancerMelanoma+10 more MacroGenics 67
Testing effectiveness (Phase 2)Looking for participantsNCT05902988What this trial is testingA Phase I/II Study of VLS-1488 in Subjects With Advanced CancerWho this might be right forAdvanced Solid TumorHigh Grade Serous Adenocarcinoma of OvarySquamous Non-small-cell Lung Cancer+7 more Volastra Therapeutics, Inc. 200
Testing effectiveness (Phase 2)Looking for participantsNCT06814496What this trial is testingRadiation Combined With BIspecific T-Cell Engager in DLL3 Expressing TumorsWho this might be right forMelanomaMedullary Thyroid CancerSinonasal Undifferentiated Carcinoma+8 more University of Arizona 30
Early research (Phase 1)Study completedNCT01772004What this trial is testingAvelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)Who this might be right forSolid Tumors EMD Serono Research & Development Institute, Inc. 1,756
Testing effectiveness (Phase 2)Study completedNCT02250885What this trial is testingKPT-330 to Treat Poorly Differentiated Lung and Gastroenteropancreatic TumorsWho this might be right forCarcinoma, Neuroendocrine Gabrail Cancer Center Research 14
Testing effectiveness (Phase 2)Study completedNCT02759835What this trial is testingLocal Ablative Therapy for Treatment of Oligoprogressive, EGFR-Mutated, Non-Small Cell Lung Cancer After Treatment With OsimertinibWho this might be right forLung AdenocarcinomaLung Neoplasms National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06946849What this trial is testingSecond-line Regimen Combined With Radiotherapy Versus Without Radiotherapy in Patients With Locally Advanced/Oligometastatic ICC After Failure of First-line Treatment：an Open-label, Randomized, Controlled Phase II Clinical StudyWho this might be right forIntrahepatic Cholangiocarcinoma (Icc) Shanghai Zhongshan Hospital 76